Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Deficit (Unaudited)

v3.23.2
Condensed Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Stock To Be Issued [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
Total
Balance, at Mar. 31, 2022 $ 500 $ 67,500 $ 96,701,607 $ 20,132,650 $ (150,036,023) $ (33,133,765)
Balance, shares at Mar. 31, 2022 5,000,000 674,644,124          
Common stock issued for legal settlement to NSH shareholders $ 6,112 19,311,486 (19,317,598)
Common stock issued for legal settlement to NSH shareholders, shares   61,154,136          
Conversion of Series E PS to common stock $ 454 839,546 840,000
Conversion of Series E PS to common stock, shares   4,537,240          
Dividends payable on Preferred Shares (102,227) (102,227)
Net loss           (2,200,176) (2,200,176)
Contingent beneficial conversion feature related to the Series E Preferred Shares, fully amortized 99,000 (99,000)
Amortization of beneficial conversion feature related to Series E Preferred Shares (42,500) (42,500)
Accretion of Series E Preferred Shares (278,500) (278,500)
Common stock issued in business agreement, to be paid from revenue earned $ 25 56,225 (56,250)
Common stock issued in business agreement, to be paid from revenue earned, shares   250,000          
Common stock vested to consultants $ 6 24,369 24,375
Balance, at Jun. 30, 2022 $ 500 $ 74,097 117,032,233 815,052 (56,250) (152,758,426) (34,892,793)
Balance, shares at Jun. 30, 2022 5,000,000 740,585,500          
Balance, at Mar. 31, 2023 $ 500 $ 80,377 121,156,733 662,767 (56,250) (167,533,292) (45,689,165)
Balance, shares at Mar. 31, 2023 5,000,000 803,123,748          
Common stock issued for legal settlement to NSH shareholders $ 86 272,657 (272,743)
Common stock issued for legal settlement to NSH shareholders, shares   863,110          
Issuance of common shares under financing agreement $ 4,019 1,294,493 1,298,512
Issuance of common shares under financing agreement, shares   40,187,311          
Conversion of Series E PS to common stock $ 2,399 825,601 (350,825) 477,175
Conversion of Series E PS to common stock, shares   23,989,570          
Dividends payable on Preferred Shares (54,000) (54,000)
Common stock issued to consultants $ 10 4,690 4,700
Common stock issued to consultants, shares   100,000          
Net loss           (2,298,431) (2,298,431)
Balance, at Jun. 30, 2023 $ 500 $ 86,891 $ 123,554,174 $ 390,024 $ (56,250) $ (170,236,548) $ (46,261,209)
Balance, shares at Jun. 30, 2023 5,000,000 868,263,739